State of Wisconsin Investment Board

SWIB's investments are managed by its own professional staff and by outside money manager firms. SWIB is required to make investment management decisions for the pension funds solely for the benefit of the members of the Wisconsin Retirement System (WRS). As fiduciaries of the pension funds, SWIB staff and Trustees are required to use the diligence, skill and care that a prudent investor would use in managing a large public pension fund.

Trustees are responsible for determining SWIB's overall investment management policies. Selection of individual investments is in the hands of staff and external money management firms. Both must make investment decisions based on extensive research, detailed analytics and judgment based on risks and potential returns. The rate of return and risk are evaluated when considering asset classes and the individual investments.

State of Wisconsin Investment Board, established in 1951 and headquartered in United States, North America., specializes in Early Stage Venture, Seed, Late Stage Venture investments across Biotechnology, Life Science, Pharmaceutical, Addiction Treatment, Venture Capital, Finance, Therapeutics, Health Care, Manufacturing, Medical Device. The organization boasts a portfolio of 29 investments, with an average round size of $14.7M and 8 successful exits. Their recent investments include Euthymics Bioscience, GBS Ventures, Novartis Venture Fund, NeuWave Medical, H.I.G. BioHealth Partners. The highest investment round they participated in was $27.0B. Among their most notable exits are Euthymics Bioscience and GBS Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.